95 related articles for article (PubMed ID: 7567130)
1. [Penetration of ceftriaxone (1 or 2 gr intravenous) into mediastinal and cardiac tissues in man].
Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M; Martin C
Pathol Biol (Paris); 1995 Apr; 43(4):364-9. PubMed ID: 7567130
[TBL] [Abstract][Full Text] [Related]
2. Penetration of ceftriaxone (1 or 2 grams intravenously) into mediastinal and cardiac tissues in humans.
Martin C; Viviand X; Alaya M; Lokiec F; Ennabli K; Said R; Pecking M
Antimicrob Agents Chemother; 1996 Mar; 40(3):812-5. PubMed ID: 8851621
[TBL] [Abstract][Full Text] [Related]
3. [Penetration of vancomycin in cardiac and mediastinal tissues in humans].
Martin C; Alaya M; Mallet MN; Viviand X; Ennabli K; Said R; de Micco P
Pathol Biol (Paris); 1994 May; 42(5):520-4. PubMed ID: 7824325
[TBL] [Abstract][Full Text] [Related]
4. [Perioperative preventive antibiotic treatment with fosfomycin in heart surgery: serum kinetics in extracorporeal circulation and determination of concentration in heart valve tissue].
Hirt SW; Alken A; Müller H; Haverich A; Vömel W
Z Kardiol; 1990 Sep; 79(9):615-20. PubMed ID: 2238772
[TBL] [Abstract][Full Text] [Related]
5. A study of plasma and cardiac tissue concentrations of ceftriaxone (Rocephin) in open heart surgery.
Faragó E; Szécsi J; Péterffy A; Mihóczy L
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):358-61. PubMed ID: 2777425
[TBL] [Abstract][Full Text] [Related]
6. Penetration of vancomycin into mediastinal and cardiac tissues in humans.
Martin C; Alaya M; Mallet MN; Viviand X; Ennabli K; Said R; De Micco P
Antimicrob Agents Chemother; 1994 Feb; 38(2):396-9. PubMed ID: 8192475
[TBL] [Abstract][Full Text] [Related]
7. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
Gersak B; Sutlic Z
Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
[TBL] [Abstract][Full Text] [Related]
8. Penetration of ofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
Mertes PM; Jehl F; Burtin P; Dopff C; Pinelli G; Villemot JP; Monteil H; Dureux JB
Antimicrob Agents Chemother; 1992 Nov; 36(11):2493-6. PubMed ID: 1489193
[TBL] [Abstract][Full Text] [Related]
9. Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.
Mertes PM; Voiriot P; Dopff C; Scholl H; Clavey M; Villemot JP; Canton P; Dureux JB
Antimicrob Agents Chemother; 1990 Mar; 34(3):398-401. PubMed ID: 2185690
[TBL] [Abstract][Full Text] [Related]
10. [Prophylactic use of cefpiramide (CPM) in open heart surgery].
Koga M; Fukuda S; Moriyama Y; Takenaka K; Iguro Y; Morishita Y; Taira A
Kyobu Geka; 1989 Nov; 42(12):991-4. PubMed ID: 2593411
[TBL] [Abstract][Full Text] [Related]
11. [Plasma and tissue concentration of ceftriaxone following a one-time i.v. dose of 2 g].
Küttel JC; Petropoulos P; Crevoisier C
Schweiz Med Wochenschr; 1988 May; 118(20):786-8. PubMed ID: 3387979
[TBL] [Abstract][Full Text] [Related]
12. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
13. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
14. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
15. Cefepime for prophylaxis of infections in the surgery of cholelithiasis. Results of a multicentric comparative trial.
Del Rio P; Vellone M; Fragapane P; di Millo M; Mazzitelli R; Allegri C; Nuzzo G; Sianesi M
Acta Biomed; 2008 Apr; 79(1):23-7. PubMed ID: 18551818
[TBL] [Abstract][Full Text] [Related]
16. The intravitreal penetration of ceftriaxone in man following systemic administration.
Sharir M; Triester G; Kneer J; Rubinstein E
Invest Ophthalmol Vis Sci; 1989 Oct; 30(10):2179-83. PubMed ID: 2793358
[TBL] [Abstract][Full Text] [Related]
17. [Early results of surgical treatment in acquired heart diseases during endocarditis in own material].
Samitowski Z; Plicner D; Drwiła R; Pietrzyk E; Kopacz J; Kapelak B; Sadowski J
Przegl Lek; 2004; 61(6):623-6. PubMed ID: 15724650
[TBL] [Abstract][Full Text] [Related]
18. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Gao B; Hu J; Deng W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
[TBL] [Abstract][Full Text] [Related]
19. [Pulmonary and tonsillar distribution of ceftriaxone and cefonicid and the resultant bactericidal activity of the organ].
Fraschini F; Scaglione F
Recenti Prog Med; 1990 Jan; 81(1):41-6. PubMed ID: 2236826
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ceftriaxone after intravenous, intramuscular and subcutaneous administration to domestic cats.
Albarellos GA; Kreil VE; Landoni MF
J Vet Pharmacol Ther; 2007 Aug; 30(4):345-52. PubMed ID: 17610408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]